MedTrace Logo

Odyssey Evaluation in Post LASIK Patients

NCT07260695 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-12-03

No results posted yet for this study

Summary

This prospective study evaluates the visual and refractive outcomes of the TECNIS Odyssey intraocular lens (IOL) implanted in patients with a history of myopic LASIK. Given the unique optical challenges of post-LASIK eyes, including altered corneal curvature and higher-order aberrations, the study aims to assess the IOL's performance in terms of distance, intermediate, and near vision, and patient satisfaction. Its design features may offer favorable outcomes in these patients.

Conditions

  • Cataract

Interventions

DEVICE

Odyssey intraocular lens

The Odyssey intraocular lens is intended to be implanted at the time of cataract surgery to replace the natural lens.

Sponsors & Collaborators

  • Sengi Clinical

    collaborator UNKNOWN

  • Center For Sight

    lead OTHER

Principal Investigators

  • Joaquin K De Rojas, MD · Center For Sight

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-18
Primary Completion
2026-08-18
Completion
2026-08-18
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07260695 on ClinicalTrials.gov